Bronchiolitis


Classification of Bronchiolar Disorders


Etiology

Infection

Toxic Fume Exposure

Other


Physiology

Infectious Bronchiolitis

Toxic Fume Bronchiolitis


Diagnosis


Clinical Presentations

Infectious Bronchiolitis

General Comments

Pulmonary Manifestations

Toxic Fume Bronchiolitis

Mild Exposure Pattern

Moderate Exposure Pattern

Severe Exposure Pattern


Treatment

Infectious Bronchiolitis

Natural Course

Infection Control/Contact Precautions

Oxygen (see Oxygen, [[Oxygen]])

Hydration

Antibiotics

Bronchodilators (see Albuterol, [[Albuterol]])

Nebulized Racemic Epinephrine (see Epinephrine, [[Epinephrine]])

Corticosteroids (see Corticosteroids, [[Corticosteroids]])

Ribavirin (see Ribavirin, [[Ribavirin]])

Palivizumab (Synagis) (see Palivizumab, [[Palivizumab]]): RSV-specific humanized monoclonal antibody

Combination Ribavirin + Intravenous Immunoglobulin (IVIG) (see Ribavirin, [[Ribavirin]] and Intravenous Immunoglobulin, [[Intravenous Immunoglobulin]])

Combination Palivizumab (Synagis) + Intravenous Immunoglobulin (IVIG) (see Palivizumab, [[Palivizumab]] and Intravenous Immunoglobulin, [[Intravenous Immunoglobulin]]): has not been studied

RSV-Specific Immunoglobulin (RSVIG)

Combination Ribavirin + Corticosteroids (see Ribavirin, [[Ribavirin]] and Corticosteroids, [[Corticosteroids]])

Toxic Fume Exposure


Prognosis


References